Literature DB >> 20736283

Orphan drugs. Relating price determination to disease prevalence.

Andrea Messori, Americo Cicchetti, Luigi Patregani.   

Abstract

Mesh：

Year:  2010        PMID： 20736283     DOI： 10.1136/bmj.c4615

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Non-profit Drug Research and Development at a Crossroads.

Authors:  Szymon Jarosławski; Mondher Toumi; Pascal Auquier; Claude Dussart
Journal:  Pharm Res       Date:  2018-02-07       Impact factor: 4.200

2.  Pricing and reimbursement of orphan drugs: the need for more transparency.

Authors:  Steven Simoens
Journal:  Orphanet J Rare Dis       Date:  2011-06-17       Impact factor: 4.123

3.  Shining a light in the black box of orphan drug pricing.

Authors:  Eline Picavet; Thomas Morel; David Cassiman; Steven Simoens
Journal:  Orphanet J Rare Dis       Date:  2014-04-27       Impact factor: 4.123

4.  Orphan Drug Pricing: An Original Exponential Model Relating Price to the Number of Patients.

Authors:  Andrea Messori
Journal:  Sci Pharm       Date:  2016-01-24

5.  Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe.

Authors:  Goran Medic; Daria Korchagina; Katherine Eve Young; Mondher Toumi; Maarten Jacobus Postma; Micheline Wille; Michiel Hemels
Journal:  J Mark Access Health Policy       Date:  2017-04-10

6.  Determinants of orphan drugs prices in France: a regression analysis.

Authors:  Daria Korchagina; Aurelie Millier; Anne-Lise Vataire; Samuel Aballea; Bruno Falissard; Mondher Toumi
Journal:  Orphanet J Rare Dis       Date:  2017-04-21       Impact factor: 4.123
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.